Pre-hospital thrombolysis in perspective

European Heart Journal

Volumn 29, Issue 23, 2008, Pages 2835-2842

  Danchin, Nicolas ^a   Durand, Eric ^a   Blanchard, Didier ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Pre hospital thrombolysis; Primary PCI; Randomized trial; Registry; ST elevation myocardial infarction

Indexed keywords

FIBRINOLYTIC AGENT; TENECTEPLASE;

ACUTE HEART INFARCTION; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CLINICAL TRIAL; FATALITY; HUMAN; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; ST ELEVATION MYOCARDIAL INFARCTION; SYMPTOMATOLOGY; TREATMENT INDICATION;

AGED; CORONARY ANGIOGRAPHY; EMERGENCY MEDICAL SERVICES; FEMALE; FIBRINOLYTIC AGENTS; HOSPITAL MORTALITY; HUMANS; MALE; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; RISK FACTORS; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 57349160246     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehn462     Document Type: Review

References (46)

1. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 2004;44:671-719.
2. Lee K, Woodlief L, Topol E, Weaver D, Betriu A, Col J, Simoons M, Aylward P, Van der Werf F, Califf R, for the GUSTO-I InvestigatorsPredictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41 021 patients. Circulation 1995;91:1659-1668.
3. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 2008;117:296-329.
4. Van de Werf F, Bax J, Betriu A, Blomstrom-Lunqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur Heart J 2008; in press.
5. Bassand JP, Danchin N, Filippatos G, Gitt A, Hamm C, Silber S, Tubaro M, Weidinger F. Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology. Eur Heart J 2005;26:2733-2741.
6. National Institute for Clinical Excellence. Technology Appraisal Guidance; http://www.nice.org.uk/nicemedia/pdf/ 52_Thrombolysis_full_guidance.pdf (2002).
7. Arntz HR, Bossaert L, Filippatos G. European Resuscitation Council Guidelines for Resuscitation 2005. Section 5. Initial management of acute coronary syndromes. Resuscitation 2005;6751:587-596.
8. Keeley E, Boura J, Grines C. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
9. Pinto D, Kirtane A, Nallamothu B, Murphy S, Cohen D, Laham R, Cutlip D, Bates E, Frederick P, Miller D, Carrozza J, Antman E, Cannon C, Gibson M. Hospital delays in reperfusion for ST-elevation myocardial infarction. Implications when selecting a reperfusion strategy. Circulation 2006;114:2019-2025.
10. Otterstad J, Brosstad F. Results from clinical trials on ST-elevation myocardial infarction in a historic perspective with some pathophysiological aspects. Scand Cardiovasc J 2003;37:316-323.
11. Morrison L, Verbeek P, McDonald A, Sawadsky B, Cook D. Mortality and prehospital thrombolysis for acute myocardial infarction. A meta-analysis. JAMA 2000;283:2686-2692.
12. Steg G, Bonnefoy E, Chabaud S, Lapostolle F, Dubien PY, Cristofini P, Leizorovicz A, Touboul P, for the Comparison of Angioplasty Prehospital Thrombolysis In acute Myocardial infarction (CAPTIM) InvestigatorsImpact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty. Circulation 2003;108:2851-2856.
13. Widimsky P, Budesínsky T, Vorác D, Groch L, Zelízko M, Aschermann M, Branny M, St'ásek J, Formánek P, on behalf of the 'PRAGUE' Study Group InvestigatorsLong distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial - PRAGUE-2. Eur Heart J 2003;24:94-104.
14. Boersma E, the PCAT-2 Trialists' Collaborative GroupDoes time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction. Eur Heart J 2006;27:779-788.
15. Fernandez-Avilés F, Alonso JJ, Castro-Beiras A, Vazquez N, Blanco J, Alonso-Briales J, Lopez-Mesa J, Fernandez-Vazquez F, Calvo I, Martinez-Elbal L, San Roman JA, Ramos B. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial. Lancet 2004;364:1045-1053.
16. Di Mario C, Dudek D, Piscione F, Savonitto S, Murena E, Dimopoulos K, Manari A, Gaspardone A, Ochala A, Zmudka K, Bolognese L, Steg PG, Flather M, on behalf of the CARESS-in-AMI investigatorsImmediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial. Lancet 2008;371:559- 568.
17. Armstrong P, WEST Steering CommitteeA comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study. Eur Heart J 2006;27:1530-1538.
18. Björklund E, Lindahl B, Stenestrand U, Swahn E, Dellborg M, Pehrsson K, Van der Werf F, Wallentin L. Outcome of ST-elevation myocardial infarction treated with thrombolysis in the unselected population is vastly different from samples of eligible patients in a large-scale clinical trial. Am Heart J 2004;148:566-573.
19. Danchin N, Vaur L, Genès N, Etienne S, Angioï M, Ferrières J, Cambou JP. Treatment of acute myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the 'real world': one-year results from a nationwide French survey. Circulation 1999;99:2639-2644.
20. Danchin N, Blanchard D, Steg P, Sauval P, Hanania G, Goldstein P, Cambou JP, Guéret P, Vaur L, Boutalbi Y, Genès N, Lablanche JM, for the USIC InvestigatorsImpact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome. Circulation 2004;110:1909-1915.
21. Andersen H, Nielsen T, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, Abildgaard U, Pedersen F, Madsen J, Grande P, Villadsen A, Krusell L, Haghfelt T, Lomholt P, Husted S, Vigholt E, Kjaergard H, Mortensen L, for the DANAMI-2 InvestigatorsA comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. New Engl J Med 2003;349:733-742.
22. Kalla K, Christ G, Karnik R, Malzer R, Norman G, Prachar H, Schreiber W, Unger G, Glogar H, Kaff A, Laggner A, Maurer G, Mlczoch J, Slany J, Weber H, Huber K, for the Vienna STEMI Registry GroupImplementation of guidelines improves the standard of care. The Viennese Registry on Reperfusion Strategies in ST-Elevation Myocardial Infarction (Vienna STEMI Registry). Circulation 2006;113:2398-2405.
23. Stenestrand U, Lindbäck J, Wallentin L, for the RIKS-HIA RegistryLong-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. JAMA 2006;296:1749-1756.
24. Björklund E, Stenestrand U, Lindbäck J, Svensson L, Wallentin L, Lindhal B, on behalf of the RIKS-HIA InvestigatorsPre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patents with ST-elevation myocardial infarction. Eur Heart J 2006;27:1146-1152.
25. McNamara R, Wang Y, Herrin J, Curtis J, Bradley E, Magid D, Peterson E, Blaney M, Frederick P, Krumholz H, for the NRMI InvestigatorsEffect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2006;47:45-51.
26. Van der Werf F. Fine-tuning the selection of a reperfusion strategy. Circulation 2006;114:2002-2003.
27. Fox K, Steg P, Eagle K, Goodman S, Anderson F, Granger C, Flather M, Budaj A, Quill A, Gore J, for the GRACE InvestigatorsDecline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007;297:1892-1900.
28. Antoniucci D, Valenti R, Migliorini A, Moschi G, Trapani M, Buonamici P, Cerisano G, Bolognese L, Santoro G. Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty. Am J Cardiol 2002;89:1248-1252.
29. Nallamothu B, Bates E, Herrin J, Wang Y, Bradley E, Krumholz H, for the NRMI InvestigatorsTimes to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States. National Registry of Myocardial Infarction (NRMI)-3/4 Analysis. Circulation 2005;111:761-767.
30. Eagle KA, Nallamothu BK, Mehta RH, Granger CB, Steg PG, Van de Werf F, López-Sendón J, Goodman SG, Quill A, Fox KA, Global Registry of Acute Coronary Events (GRACE) InvestigatorsTrends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur Heart J 2008;29:609-617.
31. Hanson TC, Williamson D. Identifying barriers to prehospital thrombolysis in the treatment of acute myocardial infarction. Emerg Med J 2006;23:650-653.
32. Price L, Keeling P, Brown G, Hughes D, Barton A. A quality study of paramedics' attitudes to providing prehospital thrombolysis. Emerg Med J 2005;22:738-741.
33. Väisänen O, Mäkijärvi M, Pietilä K, Silfvast T. Influence of medical direction on the management of prehospital thrombolysis. Resuscitation 2006;70:207-214.
34. Cambou JP, Simon T, Mulak G, Bataille V, Danchin N. The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics. Arch Mal Coeur Vaiss 2007;100:524-534.
35. Danchin N, Coste P, Ferrières J, Steg PG, Cottin Y, Blanchard D, Belle L, Ritz B, Kirkorian G, Angioi M, Sans P, Charbonnier B, Eltchaninoff H, Guéret P, Khalife K, Asseman P, Puel J, Goldstein P, Cambou JP, Simon T, for the FAST-MI InvestigatorsComparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction. Data from the French Registry on Acute ST-Elevation Myocardial Infarction (FAST-MI). Circulation 2008;118:268-276.
36. Cantor WJ, Fitchett D, Borgundvaag B, Heffernan M, Cohen EA, Morrison LJ, Ducas J, Langer A, Mehta S, Lazzam C, Schwartz B, Dzavik V, Goodman SG. Trial of Routine ANgioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction. The TRANSFER-AMI trial. SCAI-ACCi2 Summit, Chicago, 30 March 2008.
37. Ahmed S, Antman E, Murphy S, Giugliano R, Cannon C, White H, Morrow D, Braunwald E. Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials). J Thromb Thrombolysis 2006;21:119-129.
38. White H. Thrombolytic therapy in the elderly. Lancet 2000;356:2028-2030.
39. de Boer MJ, Ottervanger JP, van't Hof AWJ, Hoorntje JCA, Suryapranata H, Zijlstra F. Reperfusion therapy in elderly patients with acute myocardial infarction. A randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol 2002;39:1723-1728.
40. Danchin N, Angioi M, Demicheli T, Vaur L, Genès N, Ferrières J, Etienne S, Cambou JP. Effect of reperfusion therapy on long-term outcome in patients.70 years of age. Am J Cardiol 2002;90:1142-1145.
41. Simon T, Mary-Krause M, Cambou JP, Hanania G, Guéret P, Lablanche JM, Blanchard D, Gènes N, Danchin N, on behalf of the USIC InvestigatorsImpact of age and gender on in-hospital and late mortality after acute myocardial infarction: increased early risk in younger women. Results form the French nation-wide USIC registries. Eur Heart J 2006;27:1282- 1288.
42. Zahn R, Schiele R, Schneider S, Gitt A, Wienbergen H, Seidl K, Voigtländer T, Gottwik M, Berg G, Altmann E, Rosahl W, Senges J, for the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) the Myocardial Infarction Registry (MIR) Study GroupsPrimary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the maximal individual therapy in acute myocardial infarction registry and the myocardial infarction registry. J Am Coll Cardiol 2001;37:1827- 1835.
43. Kelly P. Thrombolysis in the pre-hospital setting. Br J Cardiol 2003;10:395-398.
44. Goldstein P, Wiel E. Management of prehospital thrombolytic therapy in ST-segment elevation acute coronary syndrome (<12 hours). Minerva Anestesiol 2005;71:297-302.
45. Henry TD, Sharkey SW, Burke N, Chavez IJ, Graham KJ, Henry CR, Lips DL, Madison JD, Menssen KM, Mooney MR, Newell MC, Pedersen WR, Poulose AK, Traverse JH, Unger BT, Wang YL, Larson DM. A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction. Circulation 2007;116:721-728.
46. Ting HH, Rihal CS, Gersh BJ, Haro LH, Bjerke CM, Lennon RJ, Lim CC, Bresnahan JF, Jaffe AS, Holmes DR, Bell MR. Regional system of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI protocol. Circulation 2007;116:729-736.